Results 201 to 210 of about 1,885,648 (256)
Some of the next articles are maybe not open access.
Statistical Uncertainty in the No-Observed-Adverse-Effect Level
Toxicological Sciences, 1989The no-observed-adverse-effect level (NOAEL) is a dose value that U.S. EPA reduces by uncertainty factors (UF) and modifying factors (MF) to obtain a reference dose (RfD) for input to regulatory decision making. Whether the true added risk at the NOAEL is below an acceptable level, however, is a source of statistical uncertainty itself.
K G, Brown, L S, Erdreich
openaire +2 more sources
No-Observed-Adverse-Effect Levels in Severity Data
Journal of the American Statistical Association, 1997Abstract Toxicity data are often categorized by severity of response and dose level with the assumption that there is a tolerated dose below which there is no toxicity. For data from a controlled experiment, the largest observed dose at or below the tolerated dose is called the no-observed-adverse-effect level (NOAEL).
Takashi Yanagawa +2 more
openaire +1 more source
2022
Many regulatory contexts require the evaluation of repeated-dose toxicity (RDT) studies conducted in laboratory animals. The main outcome of RDT studies is the identification of the no observed adverse effect level (NOAEL) and the lowest observed adverse effect level (LOAEL) that are normally used as point of departure for the establishment of health ...
Fabiola, Pizzo +2 more
openaire +2 more sources
Many regulatory contexts require the evaluation of repeated-dose toxicity (RDT) studies conducted in laboratory animals. The main outcome of RDT studies is the identification of the no observed adverse effect level (NOAEL) and the lowest observed adverse effect level (LOAEL) that are normally used as point of departure for the establishment of health ...
Fabiola, Pizzo +2 more
openaire +2 more sources
Chemical Research in Toxicology, 2020
Repeated-dose toxicity (RDT) is a critical endpoint for hazard characterization of chemicals and is assessed to derive safe levels of exposure for human health. Here we present the first attempt to model simultaneously no-observed-(adverse)-effect level (NO(A)EL) and lowest-observed-(adverse)-effect level (LO(A)EL). Classification and regression models
Domenico Gadaleta +7 more
openaire +2 more sources
Repeated-dose toxicity (RDT) is a critical endpoint for hazard characterization of chemicals and is assessed to derive safe levels of exposure for human health. Here we present the first attempt to model simultaneously no-observed-(adverse)-effect level (NO(A)EL) and lowest-observed-(adverse)-effect level (LO(A)EL). Classification and regression models
Domenico Gadaleta +7 more
openaire +2 more sources
Determination of an Acute No-Observed-Adverse-Effect Level (NOAEL) for Copper in Water
Regulatory Toxicology and Pharmacology, 2001A prospective, double-blind controlled study was designed to determine the acute no-observed-adverse-effect level (NOAEL) of nausea in an apparently healthy population of 179 individuals who drank copper-containing water as the sulfate salt. Subjects were recruited at three different international sites and given a blind, randomly selected dose (0, 2 ...
M, Araya +9 more
openaire +2 more sources

